These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36948369)

  • 1. Ligand-displaying-exosomes using RNA nanotechnology for targeted delivery of multi-specific drugs for liver cancer regression.
    Ellipilli S; Wang H; Binzel DW; Shu D; Guo P
    Nanomedicine; 2023 Jun; 50():102667. PubMed ID: 36948369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivalent rubber-like RNA nanoparticles for targeted co-delivery of paclitaxel and MiRNA to silence the drug efflux transporter and liver cancer drug resistance.
    Wang H; Ellipilli S; Lee WJ; Li X; Vieweger M; Ho YS; Guo P
    J Control Release; 2021 Feb; 330():173-184. PubMed ID: 33316298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment for Hepatocellular Carcinoma Is Enhanced When Norcantharidin Is Encapsulated in Exosomes Derived from Bone Marrow Mesenchymal Stem Cells.
    Liang L; Zhao L; Wang Y; Wang Y
    Mol Pharm; 2021 Mar; 18(3):1003-1013. PubMed ID: 33527831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes from M1-Polarized Macrophages Enhance Paclitaxel Antitumor Activity by Activating Macrophages-Mediated Inflammation.
    Wang P; Wang H; Huang Q; Peng C; Yao L; Chen H; Qiu Z; Wu Y; Wang L; Chen W
    Theranostics; 2019; 9(6):1714-1727. PubMed ID: 31037133
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhalable CAR-T cell-derived exosomes as paclitaxel carriers for treating lung cancer.
    Zheng W; Zhu T; Tang L; Li Z; Jiang G; Huang X
    J Transl Med; 2023 Jun; 21(1):383. PubMed ID: 37308954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designer exosomes for targeted and efficient ferroptosis induction in cancer via chemo-photodynamic therapy.
    Du J; Wan Z; Wang C; Lu F; Wei M; Wang D; Hao Q
    Theranostics; 2021; 11(17):8185-8196. PubMed ID: 34373736
    [No Abstract]   [Full Text] [Related]  

  • 7. Embryonic Stem Cells-Derived Exosomes Endowed with Targeting Properties as Chemotherapeutics Delivery Vehicles for Glioblastoma Therapy.
    Zhu Q; Ling X; Yang Y; Zhang J; Li Q; Niu X; Hu G; Chen B; Li H; Wang Y; Deng Z
    Adv Sci (Weinh); 2019 Mar; 6(6):1801899. PubMed ID: 30937268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular vesicles expressing a single-chain variable fragment of an HIV-1 specific antibody selectively target Env
    Zou X; Yuan M; Zhang T; Wei H; Xu S; Jiang N; Zheng N; Wu Z
    Theranostics; 2019; 9(19):5657-5671. PubMed ID: 31534509
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells.
    Kim MS; Haney MJ; Zhao Y; Mahajan V; Deygen I; Klyachko NL; Inskoe E; Piroyan A; Sokolsky M; Okolie O; Hingtgen SD; Kabanov AV; Batrakova EV
    Nanomedicine; 2016 Apr; 12(3):655-664. PubMed ID: 26586551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamer-Functionalized Exosomes: Elucidating the Cellular Uptake Mechanism and the Potential for Cancer-Targeted Chemotherapy.
    Zou J; Shi M; Liu X; Jin C; Xing X; Qiu L; Tan W
    Anal Chem; 2019 Feb; 91(3):2425-2430. PubMed ID: 30620179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell-derived exosome-entrapped paclitaxel can enhance its anti-tumor effect.
    Han D; Wang K; Zhang T; Gao GC; Xu H
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5703-5713. PubMed ID: 32495906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylgalactosamine-decorated nanoliposomes for targeted delivery of paclitaxel to hepatocellular carcinoma.
    Li T; Yu P; Chen Y; Sun B; Dong P; Zhu T; Meng X
    Eur J Med Chem; 2021 Oct; 222():113605. PubMed ID: 34126457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate-targeted polymersomes loaded with both paclitaxel and doxorubicin for the combination chemotherapy of hepatocellular carcinoma.
    Zhu D; Wu S; Hu C; Chen Z; Wang H; Fan F; Qin Y; Wang C; Sun H; Leng X; Kong D; Zhang L
    Acta Biomater; 2017 Aug; 58():399-412. PubMed ID: 28627436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A branched small molecule-drug conjugate nanomedicine strategy for the targeted HCC chemotherapy.
    Li SS; Zhang CM; Wu JD; Liu C; Liu ZP
    Eur J Med Chem; 2022 Jan; 228():114037. PubMed ID: 34883290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human umbilical cord mesenchymal stem cell-derived exosomes carrying miR-1827 downregulate SUCNR1 to inhibit macrophage M2 polarization and prevent colorectal liver metastasis.
    Chen J; Li Z; Yue C; Ma J; Cao L; Lin J; Zhu D; An R; Lai J; Guo Y; Gu B
    Apoptosis; 2023 Apr; 28(3-4):549-565. PubMed ID: 36652132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene/paclitaxel co-delivering nanocarriers prepared by framework-induced self-assembly for the inhibition of highly drug-resistant tumors.
    Wang C; Guan W; Peng J; Chen Y; Xu G; Dou H
    Acta Biomater; 2020 Feb; 103():247-258. PubMed ID: 31846802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma.
    Shi L; Tang C; Yin C
    Biomaterials; 2012 Oct; 33(30):7594-604. PubMed ID: 22796165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway.
    Lou G; Chen L; Xia C; Wang W; Qi J; Li A; Zhao L; Chen Z; Zheng M; Liu Y
    J Exp Clin Cancer Res; 2020 Jan; 39(1):4. PubMed ID: 31898515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting therapy for hepatocellular carcinoma by delivering microRNAs as exosomal cargo.
    Suda T
    World J Gastroenterol; 2024 May; 30(17):2369-2370. PubMed ID: 38813056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular Carcinoma Targeting and Pharmacodynamics of Paclitaxel Nanoliposomes Modified by Glycyrrhetinic Acid and Ferric Tetroxide.
    Zhao L; Liang L; Guo M; Li M; Yu X; Wang Y; Wang Y
    Curr Top Med Chem; 2021 Oct; 21(14):1268-1284. PubMed ID: 34620053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.